- Design
- Single-centre randomised trial, patient- and assessor-blinded
- Population
- 124 patients having elective ureterorenoscopy with lithotripsy in India
- Primary outcome
- Stent tolerability by IPSS and USSQ at 3 weeks
- Effect
- USSQ 73 vs 80 (difference -7, -13 to -1.5); grade 3 complications 8.8% vs 3.2%
This single-centre trial in India, blinded for patients and assessors, randomised 124 patients having elective ureterorenoscopy and intracorporeal lithotripsy to a 4.7Fr or 6Fr PTFE double-J stent for three weeks; 119 were analysed.
At three weeks, IPSS did not differ (mean difference -0.7, 95% CI -2 to 1), but overall Ureteral Stent Symptom Questionnaire scores were better with the thinner stent (73 vs 80; difference -7, -13 to -1.5). Stone-free rates were similar. Grade 3 complications, mainly dislodgement, were more frequent with 4.7Fr (8.8% vs 3.2%; RR 2.6, 0.5-13).
Stent symptoms are the commonest complaint after ureteroscopy and drive unplanned visits. A thinner stent is a simple change that patients noticed.
The dislodgement signal is imprecise but real enough to matter, so a thinner stent suits patients where displacement would be least harmful.
- Consider a 4.7Fr stent when a short post-ureteroscopy stent is needed.
- Prefer 6Fr where dislodgement would be dangerous, such as a solitary kidney or significant oedema.
- Warn patients about stent symptoms and give a clear removal date.
- Ask whether a stent is needed at all after uncomplicated ureteroscopy.
Why it matters
Stent discomfort is the part of stone surgery patients remember, and stent calibre is an easy lever on it.
Don't overread it
This single-centre trial was not powered for complications, so the dislodgement difference is uncertain in both directions.
The statistics, in plain English
A 7-point USSQ difference is statistically significant, with a confidence interval from 1.5 to 13 points. The dislodgement relative risk of 2.6 has an interval from 0.5 to 13, so the trial cannot tell whether thinner stents truly dislodge more often.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free